Henry DH, Glaspy J, Harrup R, Mittelman M, et al. Roxadustat for the Treatment of Anemia in Patients with Lower-Risk Myelodysplastic Syndrome: Open-label, Dose-selection, Lead-in Stage of a Phase 3 Study. Am J Hematol 2021 Nov 1. doi: 10.1002/ajh.26397.
PMID: 34724251